At present, the prognosis and therapeutic strategy for breast cancer patients mainly depend on the TNM stage of the disease, histological grade, and the expression level of hormone receptors and human epidermal growth factor receptor 2 receptors (HER2)5. This evidence concerns the gene ERBB2 and breast cancer.